Oncimmune (LON:ONC) Trading Down 13.3% – Should You Sell?

Oncimmune Holdings plc (LON:ONC)’s share price fell 13.3% during trading on Friday . The company traded as low as GBX 8.55 ($0.11) and last traded at GBX 10.80 ($0.13). 884,827 shares traded hands during mid-day trading, an increase of 240% from the average session volume of 259,890 shares. The stock had previously closed at GBX 12.45 ($0.15).

Oncimmune Stock Performance

The company has a debt-to-equity ratio of 806.85, a current ratio of 1.13 and a quick ratio of 0.63. The company has a fifty day moving average price of GBX 14.04 and a 200 day moving average price of GBX 14.86. The stock has a market cap of £7.55 million, a P/E ratio of -339.67 and a beta of 1.19.

About Oncimmune

Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.